Senseonics Holdings, a medical device maker producing implantable continuous glucose monitoring system, filed on Wednesday with the SEC to raise up to $52 million in an initial public offering. The company is currently traded on the OTCQB under symbol SENH....read more
Asante Solutions, which markets a low-maintenance insulin pump system with prefilled cartridges, withdrew its plans for an initial public offering on Tuesday. The company originally set terms to raise $49 million in February, but postponed the IPO. Another...read more
Valeritas, which markets a disposable device that delivers basal-bolus insulin therapy for Type 2 diabetes, announced terms for its IPO on Monday. The Bridgewater, NJ-based company plans to raise $75 million by offering 5 million shares at a price range of...read more
Valeritas, which markets a disposable device that delivers basal-bolus insulin therapy for Type 2 diabetes, filed on Thursday with the SEC to raise up to $90 million in an initial public offering. Valeritas' IPO filing arrives just one week after insulin...read more
Diabetes device maker Senseonics files for a $52 million IPO
Senseonics Holdings, a medical device maker producing implantable continuous glucose monitoring system, filed on Wednesday with the SEC to raise up to $52 million in an initial public offering. The company is currently traded on the OTCQB under symbol SENH....read more
PUMP deflates: Asante Solutions withdraws $49 million IPO
Asante Solutions, which markets a low-maintenance insulin pump system with prefilled cartridges, withdrew its plans for an initial public offering on Tuesday. The company originally set terms to raise $49 million in February, but postponed the IPO. Another...read more
Get even more pumped: Valeritas sets terms for $75 million IPO
Valeritas, which markets a disposable device that delivers basal-bolus insulin therapy for Type 2 diabetes, announced terms for its IPO on Monday. The Bridgewater, NJ-based company plans to raise $75 million by offering 5 million shares at a price range of...read more
Insulin device maker Valeritas files for a $90 million IPO
Valeritas, which markets a disposable device that delivers basal-bolus insulin therapy for Type 2 diabetes, filed on Thursday with the SEC to raise up to $90 million in an initial public offering. Valeritas' IPO filing arrives just one week after insulin...read more